PubRank

Mark Cook

Author PubWeight™ 43.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood 2012 2.39
2 Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia. J Clin Oncol 2005 2.20
3 Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Nephrol Dial Transplant 2012 1.62
4 Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol 2011 1.57
5 Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol 2007 1.54
6 Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 2004 1.51
7 Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol 2009 1.30
8 EEG source localization in focal epilepsy: where are we now? Epilepsia 2007 1.22
9 Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica 2009 1.17
10 Magnetic resonance imaging study in older fragile X premutation male carriers. Ann Neurol 2005 1.16
11 Australian pregnancy registry of women taking antiepileptic drugs. Epilepsia 2004 0.99
12 Determining the safety of enzymes used in animal feed. Regul Toxicol Pharmacol 2009 0.97
13 A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. Br J Haematol 2012 0.97
14 European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial. Trials 2008 0.94
15 Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma. Br J Haematol 2009 0.90
16 Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma. Blood 2008 0.90
17 Controlled delivery for neuro-bionic devices. Adv Drug Deliv Rev 2012 0.89
18 Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report. J Med Case Rep 2008 0.89
19 Global expression profiling in epileptogenesis: does it add to the confusion? Brain Pathol 2009 0.87
20 Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis. Nephrol Dial Transplant 2011 0.86
21 Ulcerative dermatitis in C57BL/6 mice lacking stearoyl CoA desaturase 1. Comp Med 2012 0.86
22 Depression in temporal lobe epilepsy surgery patients: an FDG-PET study. Epilepsia 2006 0.85
23 The prognosis of idiopathic generalized epilepsy. Epilepsia 2012 0.84
24 Association of the MELAS m.3243A>G mutation with myositis and the superiority of urine over muscle, blood and hair for mutation detection. J Clin Neurosci 2009 0.83
25 Elevated FOSB-expression; a potential marker of valproate sensitivity in AML. Br J Haematol 2008 0.83
26 Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney. J Clin Pathol 2010 0.83
27 Re-transplantation after bortezomib-based therapy. Br J Haematol 2011 0.82
28 KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation. PLoS One 2011 0.81
29 The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation. Br J Haematol 2012 0.81
30 Preoperative evaluation for temporal lobe surgery. J Clin Neurosci 2003 0.81
31 Focal abnormalities in idiopathic generalized epilepsy: a critical review of the literature. Epilepsia 2014 0.81
32 CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect. Haematologica 2010 0.81
33 Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy. BMC Clin Pathol 2012 0.80
34 The utility of ambulatory electroencephalography in routine clinical practice: a critical review. Epilepsy Res 2013 0.80
35 The electroencephalogram of idiopathic generalized epilepsy. Epilepsia 2011 0.80
36 Novel approaches for reducing free light chains in patients with myeloma kidney. Nat Rev Nephrol 2012 0.80
37 Biofortified orange maize enhances β-cryptoxanthin concentrations in egg yolks of laying hens better than tangerine peel fortificant. J Agric Food Chem 2014 0.80
38 Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations. Hum Immunol 2010 0.79
39 Prediction of intravenous cyclosporine area under the concentration-time curve after allogeneic stem cell transplantation. Ther Drug Monit 2010 0.79
40 Cost effectiveness of renal denervation therapy for the treatment of resistant hypertension in the UK. Appl Health Econ Health Policy 2014 0.79
41 Novel single base pair COX III subunit deletion of mitochondrial DNA associated with rhabdomyolysis. J Clin Neurosci 2010 0.78
42 The neurologist, psychogenic nonepileptic seizures, and borderline personality disorder. Epilepsy Behav 2007 0.76
43 Can EEG differentiate among syndromes in genetic generalized epilepsy? J Clin Neurophysiol 2016 0.76
44 Epileptiform K-Complexes and Sleep Spindles: An Underreported Phenomenon in Genetic Generalized Epilepsy. J Clin Neurophysiol 2016 0.75
45 Author Response. Neurology 2016 0.75
46 White matter changes in patients with Parkinson's disease carrying small CGG expansion FMR1 alleles: a pilot study. Neurodegener Dis 2013 0.75
47 Achieving an early myeloma response in patients with kidney impairment. Adv Chronic Kidney Dis 2012 0.75
48 Curing of oscillating larynx by levetiracetam. Arch Neurol 2011 0.75
49 Recurrent intramedullary sarcoidosis. J Clin Neurosci 2006 0.75
50 Evidence-based medicine and experience-based practice--clash or consensus? Med Law 2004 0.75
51 Intravascular large B-cell lymphoma occurring 25 years after treatment of ALK-positive anaplastic large cell lymphoma. Leuk Lymphoma 2013 0.75
52 Intracranial EEG fluctuates over months after implanting electrodes in human brain. J Neural Eng 2017 0.75
53 Specificity of psychopathology in temporal lobe epilepsy. Epilepsy Behav 2013 0.75
54 The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney. Adv Chronic Kidney Dis 2012 0.75